日本-话题@MedSci

#日本#

594篇内容 | 8346人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294535, encodeId=686b12945356e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌, objectType=article, longId=190852, objectId=502a190852b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=502a190852b7, replyNumber=0, likeNumber=63, createdTime=2020-03-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=502a190852b7, moduleTitle=日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=502a190852b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294534, encodeId=8cbb1294534cf, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=治疗14号外显子跳跃突变非小细胞肺癌（METex14）：MET抑制剂Tepmetko在日本获批, objectType=article, longId=190850, objectId=6c06190850de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c06190850de, replyNumber=0, likeNumber=68, createdTime=2020-03-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c06190850de, moduleTitle=治疗14号外显子跳跃突变非小细胞肺癌（METex14）：MET抑制剂Tepmetko在日本获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c06190850de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294533, encodeId=6d8c1294533ad, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, objectType=article, longId=190503, objectId=eb4819050376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb4819050376, replyNumber=0, likeNumber=68, createdTime=2020-03-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb4819050376, moduleTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb4819050376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294532, encodeId=cc1e129453252, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Clinica Chimica Acta：一种新的血清IgG4测定方法的评价和日本人群参考区间的估算, objectType=article, longId=190360, objectId=998019036045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=998019036045, replyNumber=0, likeNumber=59, createdTime=2020-03-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=998019036045, moduleTitle=Clinica Chimica Acta：一种新的血清IgG4测定方法的评价和日本人群参考区间的估算, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=998019036045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294531, encodeId=1e001294531dc, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本通过《新型流感等对策特别措施法》修正案，可宣布进入“紧急状态”, objectType=article, longId=189970, objectId=d31d1899e0f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d31d1899e0f5, replyNumber=0, likeNumber=59, createdTime=2020-03-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d31d1899e0f5, moduleTitle=日本通过《新型流感等对策特别措施法》修正案，可宣布进入“紧急状态”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d31d1899e0f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294530, encodeId=effc129453000, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=J Gastroenterology：维多珠单抗对日本克罗恩病患者的疗效影响——III期临床研究 , objectType=article, longId=189573, objectId=89671895e3b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89671895e3b8, replyNumber=0, likeNumber=60, createdTime=2020-03-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89671895e3b8, moduleTitle=J Gastroenterology：维多珠单抗对日本克罗恩病患者的疗效影响——III期临床研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89671895e3b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294529, encodeId=4e931294529f1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=韩国和日本新冠肺炎人数即将破千，谨防肺炎外输, objectType=article, longId=188809, objectId=1054188809c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1054188809c3, replyNumber=0, likeNumber=76, createdTime=2020-02-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1054188809c3, moduleTitle=韩国和日本新冠肺炎人数即将破千，谨防肺炎外输, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1054188809c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294528, encodeId=93ee129452803, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本胃癌治疗指南（第五版）, objectType=article, longId=188779, objectId=fdda188e79e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdda188e79e7, replyNumber=0, likeNumber=46, createdTime=2020-02-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdda188e79e7, moduleTitle=日本胃癌治疗指南（第五版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdda188e79e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294527, encodeId=3167129452ed4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2020 日本专家共识：抑郁症的药物治疗, objectType=article, longId=188773, objectId=8f5e188e73ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5e188e73ac, replyNumber=0, likeNumber=19, createdTime=2020-02-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5e188e73ac, moduleTitle=2020 日本专家共识：抑郁症的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f5e188e73ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294526, encodeId=17de129452615, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本和韩国多国新增新冠肺炎病例一日内多次创新高，WHO发警告, objectType=article, longId=188642, objectId=81b61886420b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81b61886420b, replyNumber=0, likeNumber=68, createdTime=2020-02-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81b61886420b, moduleTitle=日本和韩国多国新增新冠肺炎病例一日内多次创新高，WHO发警告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81b61886420b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294525, encodeId=7bfd129452506, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本新增14例新冠肺炎确诊病例，总数达到756人, objectType=article, longId=188585, objectId=83ca18858507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ca18858507, replyNumber=0, likeNumber=55, createdTime=2020-02-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ca18858507, moduleTitle=日本新增14例新冠肺炎确诊病例，总数达到756人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ca18858507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294524, encodeId=a66712945246c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本：下一个新冠肺炎暴发地？, objectType=article, longId=188210, objectId=dddb1882102a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dddb1882102a, replyNumber=0, likeNumber=57, createdTime=2020-02-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dddb1882102a, moduleTitle=日本：下一个新冠肺炎暴发地？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dddb1882102a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294523, encodeId=babd129452347, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本载3711人游轮新增41人确诊新型冠状病毒肺炎其中21人为日本籍, objectType=article, longId=187682, objectId=fe4718e682d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4718e682d5, replyNumber=0, likeNumber=54, createdTime=2020-02-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4718e682d5, moduleTitle=日本载3711人游轮新增41人确诊新型冠状病毒肺炎其中21人为日本籍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4718e682d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294522, encodeId=7e271294522b5, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Astellas在日本提交roxadustat的补充新药申请，用于治疗慢性肾脏疾病相关贫血, objectType=article, longId=187278, objectId=0fe318e278b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fe318e278b2, replyNumber=0, likeNumber=95, createdTime=2020-02-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fe318e278b2, moduleTitle=Astellas在日本提交roxadustat的补充新药申请，用于治疗慢性肾脏疾病相关贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fe318e278b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294521, encodeId=a55d1294521f6, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=诱导多能干细胞（iPSC）：日本京都大学团队计划将iPSC衍生的软骨移植到膝关节中, objectType=article, longId=186820, objectId=d0da18682051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0da18682051, replyNumber=0, likeNumber=142, createdTime=2020-01-29, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0da18682051, moduleTitle=诱导多能干细胞（iPSC）：日本京都大学团队计划将iPSC衍生的软骨移植到膝关节中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0da18682051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294520, encodeId=5d8f129452055, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=J Gastroenterology ：vedolizumab在日本克罗恩病患者的疗效, objectType=article, longId=186482, objectId=7b7518648237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7518648237, replyNumber=0, likeNumber=103, createdTime=2020-01-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7518648237, moduleTitle=J Gastroenterology ：vedolizumab在日本克罗恩病患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b7518648237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294519, encodeId=911d1294519c7, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2018 日本白塞病皮肤黏膜病变治疗指南, objectType=article, longId=186229, objectId=b52a18622954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b52a18622954, replyNumber=0, likeNumber=52, createdTime=2020-01-15, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b52a18622954, moduleTitle=2018 日本白塞病皮肤黏膜病变治疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b52a18622954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294518, encodeId=eff0129451831, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2019 日本脑炎疫苗应用建议, objectType=article, longId=185788, objectId=cd60185e88dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd60185e88dc, replyNumber=0, likeNumber=75, createdTime=2020-01-07, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd60185e88dc, moduleTitle=2019 日本脑炎疫苗应用建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd60185e88dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294517, encodeId=ad47129451e68, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=慢性移植物抗宿主病的治疗：Kadmon和Meiji宣布在日本合作开发ROCK2抑制剂KD025, objectType=article, longId=185345, objectId=196018534552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=196018534552, replyNumber=0, likeNumber=60, createdTime=2019-12-29, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=196018534552, moduleTitle=慢性移植物抗宿主病的治疗：Kadmon和Meiji宣布在日本合作开发ROCK2抑制剂KD025, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=196018534552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, objectType=article, longId=185338, objectId=b9ff1853386c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9ff1853386c, replyNumber=0, likeNumber=0, createdTime=2019-12-29, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9ff1853386c, moduleTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9ff1853386c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌

2020-03-27

chentianping (审核中...)

前往app查看评论内容

#日本#

治疗14号外显子跳跃突变非小细胞肺癌（METex14）：MET抑制剂Tepmetko在日本获批

2020-03-27

chentianping (审核中...)

前往app查看评论内容

#日本#

诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者

2020-03-22

chentianping (审核中...)

前往app查看评论内容

#日本#

Clinica Chimica Acta：一种新的血清IgG4测定方法的评价和日本人群参考区间的估算

2020-03-21

chentianping (审核中...)

前往app查看评论内容

#日本#

日本通过《新型流感等对策特别措施法》修正案，可宣布进入“紧急状态”

2020-03-15

chentianping (审核中...)

前往app查看评论内容

#日本#

J Gastroenterology：维多珠单抗对日本克罗恩病患者的疗效影响——III期临床研究

2020-03-10

chentianping (审核中...)

前往app查看评论内容

#日本#

韩国和日本新冠肺炎人数即将破千，谨防肺炎外输

2020-02-27

chentianping (审核中...)

前往app查看评论内容

#日本#

日本胃癌治疗指南（第五版）

2020-02-27

chentianping (审核中...)

前往app查看评论内容

#日本#

2020 日本专家共识：抑郁症的药物治疗

2020-02-27

chentianping (审核中...)

前往app查看评论内容

#日本#

日本和韩国多国新增新冠肺炎病例一日内多次创新高，WHO发警告

2020-02-24

chentianping (审核中...)

前往app查看评论内容

#日本#

日本新增14例新冠肺炎确诊病例，总数达到756人

2020-02-24

chentianping (审核中...)

前往app查看评论内容

#日本#

日本：下一个新冠肺炎暴发地？

2020-02-17

chentianping (审核中...)

前往app查看评论内容

#日本#

日本载3711人游轮新增41人确诊新型冠状病毒肺炎其中21人为日本籍

2020-02-09

chentianping (审核中...)

前往app查看评论内容

#日本#

Astellas在日本提交roxadustat的补充新药申请，用于治疗慢性肾脏疾病相关贫血

2020-02-04

chentianping (审核中...)

前往app查看评论内容

#日本#

诱导多能干细胞（iPSC）：日本京都大学团队计划将iPSC衍生的软骨移植到膝关节中

2020-01-29

chentianping (审核中...)

前往app查看评论内容

#日本#

J Gastroenterology ：vedolizumab在日本克罗恩病患者的疗效

2020-01-20

医者仁心 (审核中...)

前往app查看评论内容

#日本#

2018 日本白塞病皮肤黏膜病变治疗指南

2020-01-15

医者仁心 (审核中...)

前往app查看评论内容

#日本#

2019 日本脑炎疫苗应用建议

2020-01-07

医者仁心 (审核中...)

前往app查看评论内容

#日本#

慢性移植物抗宿主病的治疗：Kadmon和Meiji宣布在日本合作开发ROCK2抑制剂KD025

2019-12-29

医者仁心 (审核中...)

前往app查看评论内容

#日本#

吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎

2019-12-29

科室
- - 订阅+
  - 更多科室
工具
服务